| PATENT REGISTER | |||||||||||||||||||||||||||||||||
| A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2015/043 | |||||||||||||||||||||||||||||||||
| Status | Expired | Patent No. | 1613296 | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Application No. | 04726590.5 | Date of Filing | 08/04/2004 | ||||||||||||||||||||||||||||||
| Date Grant Published | 01/07/2009 | Application Published | 11/01/2006 | ||||||||||||||||||||||||||||||
| Title of Invention | METHODS FOR TREATMENT OF PARKINSON'S DISEASE | ||||||||||||||||||||||||||||||||
| Priority |
|
||||||||||||||||||||||||||||||||
| Inventors |
RUGGERO, Fariello CATTANEO, Carlo SALVATI, Patricia BENATTI, Luca |
||||||||||||||||||||||||||||||||
| Current Proprietor |
Newron Pharmaceuticals S.p.A. Via Antonio Meucci, 3 20091 Bresso (MI) ITALY |
||||||||||||||||||||||||||||||||
| Address for service |
Anne Ryan & Co 2 Crofton Terrace Dun Laoghaire Co. Dublin A96 V6P7 IRELAND |
||||||||||||||||||||||||||||||||
| Renewal Fees |
|
||||||||||||||||||||||||||||||||
| Publication Language | English | ||||||||||||||||||||||||||||||||
| Translation Received Date | |||||||||||||||||||||||||||||||||
| 08/07/2009 | Divisional Application number: 09154864.4 Publication number: 2070526 Date of receipt: 11/03/2009 | ||||||||||||||||||||||||||||||||
| 08/07/2009 | Address for Service recorded as ANNE RYAN & CO. 60 Northumberland Road, Ballsbridge, Dublin 4, Ireland received on 02/07/2009. | ||||||||||||||||||||||||||||||||
| 27/07/2015 | Request for grant a Supplementary Protection Certificate, citing Patent number 1613296 as the relevant basic patent, in respect of the product Safinamide for use in combination with levodopa/PDI, and optionally with other PD medicinal products, for the treatment of Parkinson's Disease. filed on 21/07/2015. Reference number of request is 2015/043. | ||||||||||||||||||||||||||||||||
| 14/04/2020 | Change of address of proprietor from Newron Pharmaceuticals S.p.A., Via L. Ariosto, 21, 20091 Bresso (MI), Italy to Newron Pharmaceuticals S.p.A., Via Antonio Meucci, 3, 20091 Bresso (MI), Italy recorded on 10/04/2020. Filed on spc no. 2015/043 | ||||||||||||||||||||||||||||||||
| 04/04/2024 | Request for grant of Supplementary Protection Certification No. 2015/043 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009 | ||||||||||||||||||||||||||||||||
| 07/05/2024 | Patent expired on 07/04/2024. | ||||||||||||||||||||||||||||||||
